跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cortiright 250 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cortiright 250
Approved
STANDARD
Cortiright 250
Gufic Biosciences Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7ec04a4510f2aff5
Company
Gufic Biosciences Ltd.
Type
Standard
Approval Details
Approval Id
7ec04a4510f2aff5
Drug Approval Philippines Name
Cortiright 250
Product Name
Cortiright 250
Registration Number
DRP-6685
Brand Name
Cortiright 250
Generic Name
Hydrocortisone (as sodium succinate)
Dosage Form
Lyophilized Powder For Injection (IM/IV)
Dosage Strength
250 mg
Manufacturer
Gufic Biosciences Ltd.
Importer
MedEthix, Inc.
Distributor
MedEthix, Inc.
Company Detail Path
/organization/gufic-biosciences-ltd
Issuance Date
28 April 2021
Expiry Date
14 May 2026
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7ec04a4510f2aff5
Type
Standard
Back to Philippines FDA Approvals